Aehr Test Systems (NASDAQ: AEHR) kicked off on Monday, up 8.64% from the previous trading day, before settling in for the closing price of $23.49. Over the past 52 weeks, AEHR has traded in a range of $6.27-$34.35.
During the last 5-year period, the sales drop of Technology Sector giant was -1.55%. While this was happening, its average annual earnings per share was recorded -71.58%. With a float of $27.92 million, this company’s outstanding shares have now reached $29.97 million.
Aehr Test Systems (AEHR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Semiconductor Equipment & Materials Industry. The insider ownership of Aehr Test Systems is 6.94%, while institutional ownership is 59.30%. The most recent insider transaction that took place on Oct 09 ’25, was worth 223,101. In this transaction Director of this company sold 9,000 shares at a rate of $24.79, taking the stock ownership to the 16,643 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director proposed sale 6,335 for $24.76, making the entire transaction worth $156,824.
Aehr Test Systems (AEHR) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 11/30/2024, the organization reported 0.02 earnings per share (EPS), lower than consensus estimate (set at 0.03) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -71.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 49.38% during the next five years compared to -1.55% drop over the previous five years of trading.
Aehr Test Systems (NASDAQ: AEHR) Trading Performance Indicators
Take a look at Aehr Test Systems’s (AEHR) current performance indicators. Last quarter, stock had a quick ratio of 3.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.22, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.29 in one year’s time.
